학술논문

Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study.
Document Type
Article
Source
Clinical Infectious Diseases. 1/15/2024, Vol. 78 Issue 1, p27-30. 4p.
Subject
*ANTIBIOTICS
*BACTEREMIA
*RESEARCH
*SCIENTIFIC observation
*CARBAPENEM-resistant bacteria
*ENTEROBACTERIACEAE diseases
*TREATMENT duration
*DISEASE relapse
*RISK assessment
*TREATMENT effectiveness
*DESCRIPTIVE statistics
*LONGITUDINAL method
*DISEASE risk factors
*EVALUATION
MORTALITY risk factors
Language
ISSN
1058-4838
Abstract
In a propensity-score-weighted cohort of 183 adults with carbapenem-resistant Enterobacterales bacteremia at 24 US hospitals, patients receiving short courses of active therapy (7–10 days, median 9 days) experienced similar odds of recurrent bacteremia or death within 30 days as those receiving prolonged courses of active therapy (14–21 days, median 14 days). [ABSTRACT FROM AUTHOR]